AU526214B2 - Pteridin derivatives - Google Patents

Pteridin derivatives

Info

Publication number
AU526214B2
AU526214B2 AU60106/80A AU6010680A AU526214B2 AU 526214 B2 AU526214 B2 AU 526214B2 AU 60106/80 A AU60106/80 A AU 60106/80A AU 6010680 A AU6010680 A AU 6010680A AU 526214 B2 AU526214 B2 AU 526214B2
Authority
AU
Australia
Prior art keywords
pteridin
derivatives
pteridin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU60106/80A
Other languages
English (en)
Other versions
AU6010680A (en
Inventor
Miki Akino
Takeshi Kato
Sadao Matsuura
Toshiharu Nagatsu
Takashi Sugimoto
Tokio Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm RI Pharma Co Ltd
Original Assignee
Fujifilm RI Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8456879A external-priority patent/JPH0231720B2/ja
Priority claimed from JP188480A external-priority patent/JPS5699484A/ja
Application filed by Fujifilm RI Pharma Co Ltd filed Critical Fujifilm RI Pharma Co Ltd
Publication of AU6010680A publication Critical patent/AU6010680A/en
Application granted granted Critical
Publication of AU526214B2 publication Critical patent/AU526214B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU60106/80A 1979-07-04 1980-07-04 Pteridin derivatives Ceased AU526214B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP8456879A JPH0231720B2 (ja) 1979-07-04 1979-07-04 Puterinjudotaioyobiputerinruinosokuteiho
JP8456879 1979-07-04
JP188480A JPS5699484A (en) 1980-01-11 1980-01-11 Pterin derivative and determination of pterins
JP188480 1980-07-11

Publications (2)

Publication Number Publication Date
AU6010680A AU6010680A (en) 1981-10-29
AU526214B2 true AU526214B2 (en) 1982-12-23

Family

ID=26335174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60106/80A Ceased AU526214B2 (en) 1979-07-04 1980-07-04 Pteridin derivatives

Country Status (8)

Country Link
US (1) US4371514A (OSRAM)
AU (1) AU526214B2 (OSRAM)
CA (1) CA1150243A (OSRAM)
DE (1) DE3025226C2 (OSRAM)
FR (1) FR2460952A1 (OSRAM)
GB (1) GB2056459B (OSRAM)
NL (1) NL8003854A (OSRAM)
SE (1) SE441529B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1076495B (de) * 1954-08-17 1960-02-25 Ing Ernst Godderidge Rotierende Verdraengerpumpe
US4550109A (en) * 1984-05-31 1985-10-29 The Board Of Regents, The University Of Texas System Lipoidal biopterin compounds
DE4215275A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Mittel und Verfahren zur Behandlung von Körperflüssigkeiten bei der Bestimmung von Neopterin
DE4308739C1 (de) * 1993-03-19 1994-06-23 Henning Berlin Gmbh Pterinderivate, ihre Herstellung und ihre Verwendung
US5525711A (en) * 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
US6562969B1 (en) * 1996-12-24 2003-05-13 Research Development Foundation Ricin inhibitors and methods for use thereof
ZA9711548B (en) * 1996-12-24 1999-06-23 Res Dev Foundation Ricin inhibitors and methods for use thereof
HUE029533T2 (en) * 2003-11-17 2017-03-28 Biomarin Pharm Inc Treatment of phenylketonuria with BH4
EP2436379A1 (en) 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stable tablet formulation
US20120115244A1 (en) * 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB785353A (en) * 1953-01-30 1957-10-30 Merck & Co Inc Substituted pteridine derivatives
GB785352A (en) * 1953-10-21 1957-10-30 Merck & Co Inc Preparation of pteridine derivatives
GB1458978A (en) * 1973-12-11 1976-12-22 Radiochemical Centre Ltd Saturation analysis
US4202976A (en) * 1973-09-11 1980-05-13 Bayly Russell J Selenium-75 labelled derivatives of folates
US3972991A (en) * 1974-03-18 1976-08-03 Case Western Reserve University Radioisotopic assay and binder therefor
US3989812A (en) * 1974-08-09 1976-11-02 Smithkline Instruments, Inc. Folic acid derivatives and use in radio-assay
US3988431A (en) * 1974-12-12 1976-10-26 Becton, Dickinson And Company Radioassay of folates
CA1078827A (en) * 1975-02-20 1980-06-03 Nathan Lewin Isotopically labeled derivatives of folic acid
IL49283A0 (en) * 1975-03-31 1976-05-31 Rosen I A process for the radioassay of folates and novel 125 iodinated folic acid derivatives used therein
US4028465A (en) * 1975-11-10 1977-06-07 Bio-Rad Laboratories Assay method for serum folate
US4276280A (en) * 1976-09-29 1981-06-30 Becton, Dickinson And Company Radiolabeled derivatives of folic acid
US4146602A (en) * 1977-01-27 1979-03-27 Becton, Dickinson & Company Simultaneous radioassay of folate and vitamin B12
US4136159A (en) * 1977-02-28 1979-01-23 New England Nuclear Corporation Radioassay of folates
US4135880A (en) * 1977-08-19 1979-01-23 Bio-Rad Laboratories, Inc. Folate assay with ion exchange resin bound-free separation
DE2967143D1 (en) * 1978-12-18 1984-08-30 Wachter Helmut Diagnostic method, especially for the early recognition of malignant tumors and/or viral diseases, and means to carry it out

Also Published As

Publication number Publication date
GB2056459A (en) 1981-03-18
FR2460952B1 (OSRAM) 1983-05-20
DE3025226A1 (de) 1981-01-22
AU6010680A (en) 1981-10-29
NL8003854A (nl) 1981-01-06
CA1150243A (en) 1983-07-19
SE8004933L (sv) 1981-01-05
SE441529B (sv) 1985-10-14
US4371514A (en) 1983-02-01
FR2460952A1 (fr) 1981-01-30
DE3025226C2 (de) 1982-07-22
GB2056459B (en) 1983-03-09

Similar Documents

Publication Publication Date Title
AU533566B2 (en) Aminoalkylbenzene derivatives
AU538841B2 (en) Quindine derivatives
AU542537B2 (en) Nor-tropane derivatives
AU547149B2 (en) 3-aminopropoxy - indole derivatives
AU516325B2 (en) Spiro-imidazolidinedione derivatives
AU529742B2 (en) Alkyl-ketohexopyranoside derivatives
AU547872B2 (en) Tripeptidic derivatives
AU534806B2 (en) 3-vinyl-cephalosporin derivatives
AU538138B2 (en) Methylene-cycloamine derivatives
AU533797B2 (en) Thioethylamide derivatives
AU520245B2 (en) Glycerylphosphoryl derivatives
AU526214B2 (en) Pteridin derivatives
AU5649780A (en) Biphosphite derivatives
AU538139B2 (en) 3-methyleneazetidine derivatives
AU530761B2 (en) Halo-vincamone derivatives
AU533484B2 (en) Tetrahydrochinoline derivatives
AU538087B2 (en) Halophenyl-pyridyl - allylamine derivatives
AU6119980A (en) Benzoxocin derivatives
AU538028B2 (en) 1-oxadethiacephalosporin derivatives
AU6235780A (en) Pyridazopyridazine derivatives
AU534308B2 (en) 15-hydroxyimino-e-homo-eburnane derivatives
AU5681180A (en) 2-phenyl-4-pyrone derivatives
AU543045B2 (en) 1-phenethylimidazole derivatives
AU518068B2 (en) 15-sulfonamidoprostaglandin derivatives
AU535462B2 (en) Amino-isoquinoline derivatives